Changes in commercial leadership at ImClone
This article was originally published in Scrip
Michael Bailey has resigned his position as senior vice-president of commercial operations at ImClone Systems(US), effective August 1st; he has accepted a senior level commercial position at Synta Pharmaceuticals. ImClone has also appointed Joseph DePinto vice-president of commercial operations, who will assume responsibility for the company's commercial operations department upon Mr Bailey's departure. Mr DePinto has nearly 20 years' experience in pharmaceutical sales, marketing and commercial business strategy for oncology products, and joins from Johnson & Johnson Pharmaceutical Services where he served as global marketing leader of oncology therapeutics since 2006.